Related Experiment Video
Updated: Aug 17, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
[Interventricular management of patients over the age of 75 with acute coronary syndromes without persistent ST
A Géhanne1, A Shayne, H Eltchaninoff
1Département de cardiologie, centre cardiopneumologique CHU Rennes.
Insights
Interventional strategy for elderly patients with acute coronary syndromes (ACS) showed a low rate of major adverse events. Further randomized trials are needed to confirm these benefits in older populations.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Context:
- Elderly patients (>75 years) admitted with acute coronary syndromes (ACS) without persistent ST elevation represent a vulnerable population.
- Optimal management strategies for this demographic remain an area of active investigation.
- Multicenter registry data provides insights into real-world outcomes.
Purpose:
- To assess the outcomes of an interventional strategy in patients over 75 years old admitted with ACS.
- To evaluate major cardiovascular adverse events (MACE) and complications in this elderly cohort.
- To determine the feasibility and safety of coronary angiography and percutaneous coronary intervention in this age group.
Summary:
- A multicenter registry included 126 patients (average age 79) with ACS, with 70% having poor prognostic factors.
- Coronary angiography revealed significant multi-vessel disease in most patients; percutaneous coronary intervention was performed in 82 patients.
- Hospital phase had 3 major cardiovascular complications; at 6 months, 8 (6.5%) MACE occurred, with 6 in the angioplasty group, including 5 deaths and 3 myocardial infarctions.
Impact:
- The interventional strategy in elderly ACS patients demonstrated a low rate of major adverse events.
- Findings suggest potential benefits of early revascularization in selected elderly ACS patients.
- Results highlight the need for randomized controlled trials to definitively establish the efficacy of interventional approaches in this population.
Abstract:
The aim ot tnis study was to assess the results of interventional strategy in patients over 75 years of age admitted to hospital with acute coronary syndromes (ACS) without persistent ST elevation. Over three months, patients over the age of 75 undergoing coronary angiography for ACS were included in a multicentre register and followed up for 6 months. A total of 126 patients with an average age of 79 were included: 70% had at least one poor prognostic factor. The treatment on admission included: Aspirin (84%), Clopidogrel (60%), anti GpIIb-IIIa (12%) and Heparin (81%, of which 3/4 of cases were low molecular weight heparins). Coronary angiography (average delay 80 hours) showed single, double and triple vessel disease in 21, 29 and 35% of cases respectively. Coronary angioplasty was proposed in 83 patients and carried out in 82. Eleven patients underwent coronary artery bypass grafting and 31 were treated medically. During the hospital phase, there were 3 major cardiovascular complications: 1 death during coronary angiography, 1 intra-stent thrombosis and 1 death in the group undergoing bypass grafting, with no major bleeding complications. At 6 months, there were 8 (6.5%) major cardiovascular adverse events with 6 in the "angioplasty" group; 5 deaths (3 cardiac deaths), 3 myocardial infarcts. Two thirds of patients were asymptomatic. The authors conclude that interventional strategy in ACS of elderly patients is associated with a low rate of major adverse events. The benefits of this strategy should be confirmed by randomised trial.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Angina IV: Management
Mitral Stenosis III: Medical Management